Bird & Bird ATMD advises iX Biopharma on rights issue

Contacts

marcus chow module
Marcus Chow

Partner
Singapore

We understand clients' needs, local markets, different business cultures.

jolie giouw module
Jolie Giouw

Partner
Singapore

I am a Partner in our Corporate and Commercial Group in Singapore. I am involved in a wide range of corporate matters across various sectors, with a focus on corporate finance as well as mergers and acquisitions.

xingyi tan module
Xing Yi Tan

Senior Associate
Singapore

I am a senior associate in Bird & Bird ATMD's Corporate & Commercial Group, based in Singapore. My key areas of practice include equity capital markets and mergers and acquisitions.

Bird & Bird ATMD is pleased to advise iX Biopharma, a Singapore Exchange (SGX) listed pharmaceutical company, on its renounceable non-underwritten rights issue.

Under the rights issue, each eligible shareholder can subscribe for 11 rights shares at an issue price of S$0.03 per share for every 50 existing shares held in iX Biopharma as at record date 26 June 2024. Additionally, for every two rights shares subscribed, one free warrant will be issued, allowing the holder to purchase one new share in the company at S$0.06.

iX Biopharma is undertaking the rights cum warrants issue to raise funds to, amongst others, advance the development of iXB 401 sublingual semaglutide wafers as a treatment for Type 2 diabetes and obesity, as well as to fund the sales and marketing activities of its innovative supplements including NAD+ sublingual wafers. 

Bird & Bird’s team was led by Corporate Partner Marcus Chow and supported by Counsel Jolie Giouw and Associate Tan Xing Yi.

News & Deals

More News & Deals
Deal Bird & Bird advises Siloco on the acquisition of NOVOCONT and NOVORENT

Sep 05 2025

Read More
Deal Bird & Bird advises Investronic shareholders on Evolem's equity investment

Sep 03 2025

Read More
News Bird & Bird strengthens Polish Energy & Utilities team with new partner hire

Sep 02 2025

Read More
News Bird & Bird boosts regulatory team in Brussels with double partner hire

Sep 01 2025

Read More
News Bird & Bird hires corporate crime, compliance and ESG expert David Schreuders as new partner

Sep 01 2025

Read More
News Bird & Bird recognised in World IP Review (WIPR) Global Trade Secrets Ranking 2025

Aug 27 2025

Read More